Drug Database · Clinicians

Carbocisteine + Salbutamol

Also known as: carbocysteine (US name, for carbocisteine) · albuterol (US name, for salbutamol)

Brands (1) Solmux BronchoShow all

Bronchodilator/ mucolytic PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Excess viscous mucus (adjunct; including chronic obstructive airways disease) renalcarematters.com, reviewed

    Kidney dosing: Carbocisteine (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Usual dose: 2,250 mg/day in divided doses (two 375 mg capsules three times daily), reduced to 1,500 mg/day (one capsule four times daily) once response is achieved (SmPC).
    CrCl 30–59 mL/min
    The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
    CrCl 15–29 mL/min
    The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
    CrCl <15 mL/min (not on dialysis)
    The SmPC gives no kidney dosing and no kidney pharmacokinetic data. Use with caution and specialist judgment.
    Hemodialysis (intermittent)
    Not studied in dialysis; no dose given.
    Peritoneal dialysis
    Not studied in dialysis; no dose given.
    CRRT
    Not studied in dialysis; no dose given.
    • Dialyzable? Not stated.
    • Monitoring Gastrointestinal bleeding, especially in older adults, ulcer history or with drugs that cause bleeding; stop if bleeding occurs (SmPC 4.4).

    From the Carbocisteine monograph (renalcarematters.com, reviewed).

  • Use: INDICATIONS AND USAGE Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Capsule: 2 mg/500 mg
  • Suspension: 2 mg/500 mg per 5 mL

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Carbocisteine + Salbutamol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Carbocisteine + Salbutamol
Package insert
Solmux BronchoSalbutamol + Carbocisteine
2 mg / 500 mg per 5 mL SuspensionAmber Bottle x 60 mL
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-14219
Jan 24, 2030
Solmux BronchoSalbutamol (as sulfate) + Carbocisteine
2 mg/ 500 mg CapsuleAluminum Foil Strip x 4's (Box of 100's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY678
May 31, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .